4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001933414-25-000077
CFO and Secretary sold 10,758 shares at $14.45 ($155,454)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Levy Adam Scott CFO and Secretary | 2025-07-11 | Sale 10b5-1 | −10,758 | $14.45 | $155,454 | 206,612 | D |
| Open-market sales · 10,758 sh · avg $14.45 · $155,454 | |||||||
Loading xslF345X05/wk-form4_1752613283.xml…